ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN

Cellectis S.A. · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
blastic plasmacytoid dendritic cell neoplasm (bpdcn), blastic plasmacytoid dendritic cell neoplasm, natural killer (nk) cell blastic lymphoma, hematologic malignancies, cluster of differentiation (cd) cd4+cd56+ hematodermic tumor, acute leukemia and myeloid neoplasms, chimeric antigen receptor t-cell (car-t) therapy, allogeneic, cluster of differentiation 4 (cd4), cluster of differentiation 56 (cd56), interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 861618
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.